RESEARCH AND DEVELOPMENT WORK Sample Clauses

RESEARCH AND DEVELOPMENT WORK. Research and development work related to the Products and the Newco Intellectual Property shall be conducted in accordance with the research and development program developed by the R&D Committee and approved by the Management Committee.
RESEARCH AND DEVELOPMENT WORK. Subject to Clause 6.3, Elan and Sheffield, at Newco's request, may undertake research and development work related to the development and commercialization of the Products, at the request of Newco and as articulated in the Business Plan, in furtherance of the development and commercialization of the Products and cultivation of patent rights and know-how related to the Elan Intellectual Property, Sheffield Intellectual Property and Newco Intellectual Property.
RESEARCH AND DEVELOPMENT WORK. During the Research Term, Newco will diligently pursue the research and development of the Elan Intellectual Property, Isis Intellectual Property and Newco Technology in accordance with the Research and Development Program. The "RESEARCH AND DEVELOPMENT PROGRAM" will be the program for (a) the development of the Oral Platform, and (b) the development of the Development Product in the Field, including without limitation, screening, in-vitro pharmacology, toxicology, stability, prototype dosage form development, formulation, optimization, clinical and regulatory activities. Such work shall be agreed to and conducted by Elan and/or Isis under contract with Newco as provided in the Business Plan.
RESEARCH AND DEVELOPMENT WORK. 1.1 The Parties shall commence the performance of the Project promptly after the Effective Date of this Agreement. 1.2 The Parties shall work together to cooperate the joint research and development product in accordance with the Joint Research and Development Project Plan set out in Appendix 1. 1.3 Each Party shall use reasonable efforts to: (i) Perform its responsibilities in accordance with this Agreement and the Joint Research and Development Project Plan and perform all Joint Research and Development Plan requirements, including by meeting all Joint Research and Development Plan timelines and milestones; and (ii) Cooperate with and provide reasonable support to the other Party in connection with the other Party’s performance of its obligations under this Agreement including the Joint Research and Development Plan.
RESEARCH AND DEVELOPMENT WORK. 9.1 During the Research Term, Newco will diligently pursue the research and development of the Elan Intellectual Property, TGEN Intellectual Property and Newco Technology in accordance with the Research and Development Program. The "Research and Development Program" will be the program for (a) the development of the Platform, and (b) the development of one or more Products in the Field, including without limitation, screening, in-vitro pharmacology, toxicology, stability, prototype dosage form development, formulation, optimization, clinical and regulatory activities. Such work shall be agreed to and conducted by Elan and/or TGEN under contract with Newco as provided in the Business Plan. 9.2 The Research and Development Program shall include a Feasibility Phase, a Development Phase and a Clinical Phase. During the Feasibility Phase, Newco will diligently pursue the research and development of the Feasibility Studies and the Program Technology. The objectives of this initial phase of research and development work will be to develop the Platform which can be broadly applied in the delivery of a variety of Products. The foregoing shall be provided for in the Research and Development Program. 9.3 On successful completion of the Feasibility Phase and the designation of one or more Products to be developed by Newco, Elan and TGEN shall meet to discuss the development and commercial strategy for Newco and the further exploitation of the technologies and Products vested in Newco. For example, TGEN and Elan shall discuss strategy and terms relating to product and clinical development, corporate partnering, licensing and supply agreements. 9.4 TGEN and Elan shall provide such research and development services as may be reasonably required by Newco in accordance with the provisions in the License Agreements. Newco shall pay TGEN and Elan for any research and development work carried out by them on behalf of Newco at the end of each month during the Research and Development Program, subject to the proper vouching of research and development work and expenses. An invoice shall be issued to Newco by TGEN or Elan, as applicable, by the 15/th/ day of the month following the month in which work was performed, or as soon thereafter as practicable. Newco shall pay the amounts invoiced within thirty days following its receipt of the invoice. The payments by Newco to TGEN or Elan, as the case may be, shall be at the rates prescribed in the respective License Agreement. Resear...
RESEARCH AND DEVELOPMENT WORK. Subject to the provisions of Clause 6.3 and Clause 6.4, each of Elan and SafeScience may, at its respective discretion, provide research and development services to Newco, at the request of Newco and as articulated in the Business Plan, in furtherance of the development of the Products and cultivation of patent rights and know-how related to the Elan Intellectual Property, SafeScience Intellectual Property and Newco Intellectual Property.
RESEARCH AND DEVELOPMENT WORK. 3.3.1 XXXXXXX could work in association with UQUAT and, should the occasion arise, with organizations which could bring in subsidies or corporations in partnership, to carry out research projects for the purpose of improving and developing applications related to the System. The projects will be the object of distinct contracts and will be prepared in reference to the hereby master agreement. The intellectual property Rights on the System and its improvements originating from these contracts will belong to UQUAT and XXXXXXX will benefit from an exclusive and perpetual operating licence. Contracts will necessarily contain an agreement which will take into account the respective field of each partner and should determine the extent as well as the terms and conditions to the awarding of the aforementioned licence. UQUAT will benefit from a publication right for scientific articles, presentation of results during scientific conferences and a right of utilization without any limit of time for the purpose of education and research, subject to provisions relative to intellectual Property protection, its valuation, its trade secrets, or elements relative to commercial and industrial stategies, determined in specific mandates and contracts. 3.3.2 UQUAT can undertake and carry out on its own, research projects relative to the System or requiring the utilization of one or several parts of the System. Such projects will be presented to XXXXXXX beforehand, who could choose to be associated to the University to carry them out, in which case, provisions of article 3. 3.1 will apply. However, the intellectual property will be owned by the University if XXXXXXX refuses to get associated to a project proposed by UQUAT. In that case, XXXXXXX will be provided with a right of first refusal on an operating license. The aforementioned license will be the object of a negotiated agreement. These projects will be carried out according to the availability of equipments. Subject to XXXXXXX'X participation, the intellectual property resulting from these projects will be owned by the University.
RESEARCH AND DEVELOPMENT WORK. Subject to the provisions of Clause 6.3, Elan and Photogen, at Newco's request, may undertake research and development work related to the development and commercialization of the Products, at the request of Newco and as articulated in the Business Plan, in furtherance of the development and commercialisation of the Products and cultivation of patent rights and know-how related to the Elan Intellectual Property, Photogen Intellectual Property and Newco Intellectual Property.
RESEARCH AND DEVELOPMENT WORK. During the Research Term, HepaSense will diligently pursue the research and development of the Elan Intellectual Property, Isis Intellectual Property and HepaSense Intellectual in accordance with the Research and Development Program. The "RESEARCH AND DEVELOPMENT PROGRAM" will be the program the development of the Product in the Field, including without limitation, in vivo toxicology, stability, formulation, optimization, clinical and regulatory activities. Such work shall be agreed to and conducted by Elan, Isis and/or a third party Isis under contract with HepaSense as provided in the Business Plan.
RESEARCH AND DEVELOPMENT WORK. Research and development work, if any, will require a separate agreement albeit on substantially similar terms to the process development and validation agreement agreed between the parties and dated 15th March 2006.